Yahoo España Búsqueda web

Search results

1. pubmed.ncbi.nlm.nih.gov › 30206110The Genetic Landscape and Clonal Evolution of Breast Cancer ... -...

   pubmed.ncbi.nlm.nih.gov › 30206110

   Abstract. CDK4/6 inhibition with endocrine therapy is now a standard of care for advanced estrogen receptor-positive breast cancer. Mechanisms of CDK4/6 inhibitor resistance have been described preclinically, with limited evidence from clinical samples.

2. www.facebook.com › public › Ben-OLearyBen OLeary Profiles | Facebook

   www.facebook.com › public › Ben-OLeary

   Ben O'Leary. See Photos. View the profiles of people named Ben OLeary. Join Facebook to connect with Ben OLeary and others you may know. Facebook gives people the power to share...

3. Imágenes

   • 
   • 
   • 
   • 
   • 
   • 

   Ver todo

4. academic.oup.com › jnci › articleCirculating Tumor DNA Markers for Early Progression on...

   academic.oup.com › jnci › article

   • En caché

   17 de jun. de 2020 · Ben O’Leary, Rosalind J Cutts, Xin Huang, Sarah Hrebien, Yuan Liu, Fabrice André, Sibylle Loibl, Sherene Loi, Isaac Garcia-Murillas, Massimo Cristofanilli, Cynthia Huang Bartlett, Nicholas C Turner, Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer, JNCI ...

5. loop.frontiersin.org › people › 1234166Loop | Ben O'Leary

   loop.frontiersin.org › people › 1234166

   1 de oct. de 2020 · Ben's current research is focused on understanding the evolution of resistance to cancer therapies in breast and head and neck cancers. Ben's undergraduate training included Aerospace Engineering at The University of Cambridge and then Medicine at King's College London.

6. www.icr.ac.uk › our-research › researchers-and-groupsDr Ben O'Leary - The Institute of Cancer Research, London

   www.icr.ac.uk › our-research › researchers-and-groups

   • En caché

   23 de feb. de 2024 · Dr Ben O'Leary is an NIHR Academic Clinical Lecturer in Molecular Oncology who is researching the evolution of resistance to cancer therapies at the ICR. Ben O'Leary is a Clinician Scientist at the ICR and an Honorary Consultant in Clinical Oncology at The Royal Marsden hospital, working in the Molecular Oncology group.

7. www.royalmarsden.nhs.uk › consultant-directory › dr-ben-olearyDr Ben O’Leary | The Royal Marsden

   www.royalmarsden.nhs.uk › consultant-directory › dr-ben-oleary

   • En caché

   Dr Ben O’Leary. Clinician Scientist and Honorary Consultant in Clinical Oncology MA Cantab, MBBS, MSc, MRCP, FRCR, PhD. Specialism: Head and neck. Available at: Chelsea. Special interests. Head and neck cancer. Clinical trials. Translational research. Liquid biopsies. Cancer evolution. Novel therapies. Biography.

8. pubmed.ncbi.nlm.nih.gov › 36369554Recent advances in the oncological management of head and neck...

   pubmed.ncbi.nlm.nih.gov › 36369554

   Authors. Ben O Leary 1 , Adam Young 2 , Christopher Nutting 3. Affiliations. 1 Clinician Scientist, The Institute of Cancer Research, London, UK; Consultant Clinical Oncologist, The Royal Marsden Hospital, London, UK. ben.oleary@icr.ac.uk. 2 Internal Medicine Trainee, Imperial College Healthcare NHS Trust, UK.